Immunomedics (IMMU) Receives New U.S. Patent Covering IMMU-130
Tweet Send to a Friend
Immunomedics, Inc., (Nasdaq: IMMU) announced the issuance of U.S. Patent 9,458,242 for additional claims under the patent family “Dosages of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE